Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM). (NCT06297512)Iacopo Sardi2022-12-09
CD30 CAR for CD30+ NSGCT (NCT05634785)UNC Lineberger Comprehensive Cancer Center2022-12-09
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) (NCT05657873)Memorial Sloan Kettering Cancer Center2022-12-09
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer (NCT05827796)InxMed (Shanghai) Co., Ltd.2022-12-08
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC) (NCT05630612)University of Edinburgh2022-12-08
A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) (NCT05686239)Recognify Life Sciences2022-12-08
Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19 (NCT05676073)Shenzhen Kexing Pharmaceutical Co., Ltd.2022-12-08
PVd Versus Vd in NDMM Patients With RI (NCT05432414)RenJi Hospital2022-12-08
Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US (NCT05211284)Zydus Therapeutics Inc.2022-12-08
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain (NCT05630196)Eli Lilly and Company2022-12-08
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation (NCT05610163)Alliance for Clinical Trials in Oncology2022-12-08
Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine (NCT05641246)German University in Cairo2022-12-08
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma (NCT04756401)Academic and Community Cancer Research United2022-12-08
A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies (NCT05654038)920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2022-12-08
A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma (NCT05653427)Janssen Research & Development, LLC2022-12-08
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer (NCT05513742)Compass Therapeutics2022-12-08
Exenatide for Smoking Cessation and Prevention of Weight Gain (NCT05610800)The University of Texas Health Science Center, Houston2022-12-07
GH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early Results (NCT06310382)Suzhou Genhouse Bio Co., Ltd.2022-12-07
Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) (NCT04968106)Institut Bergonié2022-12-07
ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection (NCT06342921)Jiaxing AnDiCon Biotech Co.,Ltd2022-12-07
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer (NCT05211323)National Cancer Institute (NCI)2022-12-07
Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery (NCT05594290)Gruppo Oncologico del Nord-Ovest2022-12-07
Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (NCT05635838)Incyte Corporation2022-12-07
Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia (NCT05509595)National Institute of Dental and Craniofacial Research (NIDCR)2022-12-07
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) (NCT05579366)Genmab2022-12-07
Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load (NCT05968846)University of Tennessee Graduate School of Medicine2022-12-07
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T (NCT05886257)Shi Ming2022-12-07
Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19 (NCT05125562)Direct Biologics, LLC2022-12-07
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) (NCT04915404)WPD Pharmaceuticals Sp. z o.o.2022-12-07
Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis (NCT05706870)GEN İlaç ve Sağlık Ürünleri A.Ş.2022-12-07
Incidence of Caesarean Scar Defect in Cases of Cesarean Section With and Without Bladder Flap Dissection (NCT06503627)Alexandria University2022-12-07
Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer (NCT05340309)University of Southern California2022-12-07
Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure (NCT05652322)Jan Kochanowski University2022-12-07
Add-on Reparixin in Adult Patients With ARDS (NCT05496868)Dompé Farmaceutici S.p.A2022-12-06
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study (NCT05361720)Vanderbilt-Ingram Cancer Center2022-12-06
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine (NCT05679908)Tonix Pharmaceuticals, Inc.2022-12-06
A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis (NCT05601778)Haisco Pharmaceutical Group Co., Ltd.2022-12-06
A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 (NCT05473195)TASK Applied Science2022-12-06
Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy (NCT05638776)Regend Therapeutics2022-12-06
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer (NCT05616494)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2022-12-06
Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease (NCT05388149)University Health Network, Toronto2022-12-06
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer (NCT05555706)Shanghai Jiaolian Drug Research and Development Co., Ltd2022-12-06
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation. (NCT05445843)Novartis Pharmaceuticals2022-12-06
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma (NCT05564052)Janssen Research & Development, LLC2022-12-06
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study (NCT05136196)National Cancer Institute (NCI)2022-12-06
Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial (NCT05189106)Massachusetts General Hospital2022-12-05
AB1 in Adult Patients with Sickle Cell Disease (SCD) (NCT05261711)Nirmish Shah2022-12-05
Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL (NCT05639179)920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2022-12-05
Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer (NCT05653856)Curium US LLC2022-12-05
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC (NCT05645380)University of Kansas Medical Center2022-12-05
Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas (NCT05737212)Dawonmedax Co., Ltd.2022-12-05
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer (NCT05558722)Xijing Hospital2022-12-05
Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome (NCT05605665)Peking University People's Hospital2022-12-05
Cord Blood Cells in Patients With Acute SCI (NCT05693181)Sklifosovsky Institute of Emergency Care2022-12-05
Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men (NCT05636904)Dermaliq Therapeutics, Inc.2022-12-05
Skin Change Actions by Nursing (NCT06127524)University of California, Los Angeles2022-12-04
Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol) (NCT05508074)InFlectis BioScience2022-12-02
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations (NCT05651672)Tianjin Medical University Cancer Institute and Hospital2022-12-02
DC/NK Cell Therapy (NCT07202611)National Taiwan University Clinical Trial Center2022-12-02
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC (NCT06241807)Shandong Cancer Hospital and Institute2022-12-02
Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection. (NCT06220344)HITEC-Institute of Medical Sciences2022-12-02
Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health (NCT05616260)University of California, San Diego2022-12-02
Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer (NCT05618613)Context Therapeutics Inc.2022-12-02
Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) (NCT05602727)Merck Sharp & Dohme LLC2022-12-02
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial (NCT02875262)Radboud University Medical Center2022-12-02
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma (NCT05518994)Henan Provincial People's Hospital2022-12-01
A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis (NCT05359406)LI XIN-XIANG2022-12-01
Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment (NCT04625699)Catherine Shu2022-12-01
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas (NCT05663125)Beijing Tiantan Hospital2022-12-01
Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer (NCT05508737)Yonsei University2022-12-01
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer (NCT05634590)Fudan University2022-12-01
Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy (NCT05373316)Radboud University Medical Center2022-12-01
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (NCT05588219)Yong Zhang,MD2022-12-01
Cognitive Reserve-building Activities in Multiple Sclerosis (NCT05691192)Rigshospitalet, Denmark2022-12-01
Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia (NCT05660785)Institute of Hematology & Blood Diseases Hospital, China2022-12-01
In-hospital Clinical Outcome of Deferred Stenting Versus Immediate Stenting in the Management of Acute STEMI Presenting With High Thrombus Burden. (NCT05647018)Assiut University2022-12-01
The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device (NCT05599477)Radboud University Medical Center2022-12-01
A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis (NCT05604261)Xuanzhu Biopharmaceutical Co., Ltd.2022-12-01
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR (NCT05570383)People's Hospital of Anshun City of Guizhou Province2022-12-01
Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma (NCT05755828)The Affiliated Hospital of Xuzhou Medical University2022-12-01
Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC (NCT05721443)Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2022-12-01
Dexamethasone/ Erector Spinae Plane Block Analgesia in Laparoscopic Cholecystectomy (NCT05105997)Assiut University2022-12-01
Magnesium Treating Subarachnoid Hemorrhage Vasospasm (NCT04613960)General Committee of Teaching Hospitals and Institutes, Egypt2022-12-01
Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma (NCT05386056)Peking University2022-12-01
A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs (NCT05556200)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2022-12-01
8.4% Sodium Bicarbonate Locks in Intestinal Failure (NCT05813535)Riad Rahhal2022-12-01
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia (NCT05117346)Cardix Therapeutics LLC2022-12-01
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer (NCT05600127)Erasmus Medical Center2022-12-01
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT05603884)The First Affiliated Hospital of Xiamen University2022-12-01
A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients (NCT05662956)Hematology department of the 920th hospital2022-12-01
Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean Section (NCT05654649)Assiut University2022-12-01
The Lived Experiences Measured Using Rings Pilot Study (NCT05841979)University of Vermont2022-12-01
Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis (NCT05569538)The University of Hong Kong2022-12-01
Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS (NCT05302570)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2022-12-01
OsciPulse D-dimer Efficacy Trial (NCT05389488)OsciFlex LLC2022-12-01
Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy (NCT05663801)Beni-Suef University2022-12-01
Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML) (NCT05682170)K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.2022-12-01
Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma. (NCT05493618)Hackensack Meridian Health2022-12-01
Synapse 3D With Intravascular Indocyanine Green (NCT03953144)St. Joseph's Healthcare Hamilton2022-12-01
Rice Bran-based Supplemental Foods for the Treatment of Childhood Malnutrition (NCT05319717)Colorado State University2022-12-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.